Genomelink
Founded Year
2017Stage
Seed - II | AliveTotal Raised
$4.49MMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-252 points in the past 30 days
About Genomelink
Genomelink is a personal genomics company that provides Deoxyribonucleic acid(DNA) analysis and insights. The company offers a platform for users to upload their raw DNA data to receive a wide range of reports on ancestry, wellness, and personal traits. Genomelink targets individuals interested in exploring their genetic makeup and gaining personalized insights into their health, ancestry, and personal characteristics. It was founded in 2017 and is based in Berkeley, California.
Loading...
Loading...
Research containing Genomelink
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Genomelink in 1 CB Insights research brief, most recently on Dec 19, 2022.
Expert Collections containing Genomelink
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Genomelink is included in 1 Expert Collection, including Digital Health.
Digital Health
11,074 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Genomelink Patents
Genomelink has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
4/24/2018 | Social networking services, Parallel computing, Genomics, Bioinformatics, Biological databases | Application |
Application Date | 4/24/2018 |
---|---|
Grant Date | |
Title | |
Related Topics | Social networking services, Parallel computing, Genomics, Bioinformatics, Biological databases |
Status | Application |
Latest Genomelink News
Aug 29, 2017
August 22, 2017 09:00 AM Eastern Daylight Time SAN FRANCISCO--( BUSINESS WIRE )--Now based in the genomics center of the Silicon Valley, the consumer genomic startup, AWAKENS, Inc., hails from Tokyo, Japan. Though consumer genomics is just picking up the pace, the founders at AWAKENS envision a future in which every human owns and can easily access their whole genome data. AWAKENS was founded with the goal of empowering each individual to build a smarter and healthier lifestyle based on their genetic makeup, and to transform consumer genomics. AWAKENS has launched their first consumer product GENOMIC EXPLORER ( https://genomicexplorer.io ). The service is currently free for genome data holders, such as those who have taken ancestry genetic tests. New users can order their whole genome sequence through the website ( https://genomicexplorer.io ). Users with whole genome data will also be able to upload their data soon. Visualize Your Inner Universe with “GENOMIC EXPLORER” Full access to whole genome data and reliable information on how to interpret the data is AWAKENS’ top value proposition. Most genetic testing services today read only 0.03% of the genome. GENOMIC EXPLORER reads and visualizes 100%. AWAKENS strives to visualize what existing genetic testing services have abstracted in their genetic reports. You can browse through a comprehensive visual representation of your genome and learn about 100+ traits: this tool connects your genome data to an in-house annotation database, which tells you how specific regions of the genome can be understood. Traits include personality, intelligence, and nutrition. The only information serving the purpose of science education are released in the U.S for now. Information on medical traits, such as the risk for a certain disease, will be provided in the future as partnerships with healthcare institutions and healthcare companies are established. “Today for the genome is like the 90s for the Internet. Although technological innovations made the Internet accessible for many, applications for daily use had not been developed. Everyone was scrambling to figure out how to make the best use of the Internet,” explained Tomohiro Takano, CEO and Co-Founder of AWAKENS, Inc. “Through partnerships with many industries, we at AWAKENS are striving to unlock the vast potential of the whole genome. We want to develop an ecosystem where anyone can access valuable information, actionable insights, and related services based on their genetic information.” The field of genomics 15 years ago, sequencing the whole genome cost 3 billion USD. 5-10 years from now, the price will drop to a few hundred USD. Against the backdrop of these circumstances, we can expect to gain access to a wide range of consumer genomics services in our daily lives, spanning medicine, healthcare, nutrition, fitness, and education. Soon, pharmacogenomics will inform drug efficacy and risk of serious side effects at the individual level. Beyond medical applications, academic research in fitness and genomics, nutrigenomics, and educational genomics are booming. The potential for consumer applications will only grow from here. About AWAKENS, Inc. AWAKENS is a genomic software company transforming the landscape of consumer genomics. They empower consumers with easily accessible insights of their own genome data, and diversify consumer genomics services by providing an API toolkit for existing services to provide personalized solutions tailored to each person’s genetic makeup. Founded in January 2017 in Tokyo, Japan, AWAKENS is currently located in the genomic center in Silicon Valley. The company’s products include the consumer-facing GENOMIC EXPLORER and the business-facing GENOME LINK. Awakens is funded by private corporations and angel investors (as of Aug 2017): 500 Startups Japan https://500startups.jp
Genomelink Frequently Asked Questions (FAQ)
When was Genomelink founded?
Genomelink was founded in 2017.
Where is Genomelink's headquarters?
Genomelink's headquarters is located at 2150 Shattuck Avenue, Berkeley.
What is Genomelink's latest funding round?
Genomelink's latest funding round is Seed - II.
How much did Genomelink raise?
Genomelink raised a total of $4.49M.
Who are the investors of Genomelink?
Investors of Genomelink include Brighter Capital, Liquid 2 Ventures, Y Combinator, Berkeley SkyDeck, Digital Garage and 13 more.
Who are Genomelink's competitors?
Competitors of Genomelink include LetsGetChecked and 3 more.
Loading...
Compare Genomelink to Competitors
Color specializes in genetic testing and health services, focusing on early detection and management of cancer and hereditary diseases. The company offers genetic screenings to assess the risk for hereditary cancer and heart conditions, as well as services to understand medication responses, aiming to facilitate preventative health measures and personalized care plans. Color primarily serves employers, health plans, unions, and clinicians, providing them with tools to manage the health of their populations. Color was formerly known as Color Global. It was founded in 2014 and is based in Burlingame, California.
24Genetics is a biotechnology company that specializes in the field of Direct to Consumer Genetic tests. The company offers a wide range of DNA tests that provide information about an individual's health, nutrition, sports performance, ancestry, and skincare. These tests are designed to help individuals improve their health and wellbeing through a better understanding of their genetics. It was founded in 2010 and is based in Boston, Massachusetts.
imaware is a health technology company specializing in at-home health testing solutions across various health domains. The company offers a range of at-home test kits that screen and monitor conditions related to men's health, women's health, heart health, diabetes, immune health, and sexual health. imaware primarily serves individuals seeking convenient and private health monitoring, as well as businesses looking for scalable health testing solutions. It was founded in 2018 and is based in Houston, Texas.
Palta develops a range of application-based products in the digital health segment. It provides insights into the health and behavioral habits of customers and helps them detect health problems through artificial intelligence (AI) systems. Its applications focus on preventative healthcare and well-being. It was formerly known as Haxus Ventures. It was founded in 2016 and is based in London, United Kingdom.
OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.
Molecular You is a developer of a digital personalized health platform designed to deliver comprehensive health information and individualized health action plans. Molecular You leverages a multi-biomarker analytics platform that includes proteomic and metabolomic data to create highly accurate predictive risk profiles for over 26 health conditions. Molecular You's AI-powered platform analyzes a comprehensive set of over 250 biomarkers to provide early detection of potential health risks and deliver personalized nutrition, exercise, and supplement recommendations through a user-friendly web interface. This approach not only enhances individual health outcomes but also supports healthcare providers in delivering value-based care by improving health assessment, patient engagement, and preventative health strategies. Through its emphasis on precision medicine, Molecular You advances the field of personalized medicine by tailoring health insights and interventions to each individual's unique molecular profile. It was founded in 2014 and is based in Vancouver, Canada.
Loading...